Therese Choquette
Chief Technical Officer Tigen Pharma SA
Seminars
Thursday 19th November 2026
Accelerating TIL Manufacturing Through Automated QC Release Testing & Next-Generation Potency Assays
9:00 am
- Sharing strategies to accelerate product release through automated quality control workflows, rapid sterility testing, and conditional release approaches to reduce manufacturing bottlenecks
- Exploring how automation can improve consistency, scalability, and efficiency across TIL manufacturing while maintaining product quality and regulatory compliance
- Discussing current challenges in developing meaningful potency assays for TIL products and evaluating emerging approaches to better characterize product function and predict clinical performance
